SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedixs stronger-than-expected quarterly results and higher adjusted EBITDA outlook, alongside a DefenCath agreement with DaVita, are driving attention. Bulls see commercial momentum across major dialysis providers, while skeptics question how durable growth will be as reimbursement shifts beyond TDAPA and the share price has struggled to hold gains.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins prolonged slide to 52-week lows is being tied to a court denial of its request to temporarily block Unitys Ad Quality SDK, alongside analyst concerns about competition and Pixel adoption; the underlying lawsuit remains active. Traders are divided over whether the dispute and growth concerns justify the selloff or whether it is overdone given the companys profitability and growth, with analyst reports also drawing blame.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A much weaker-than-expected jobs report pushed Treasury yields lower and eased expectations for another Fed rate hike, helping IWM rebound from its 200-day moving average. Traders welcomed the rate-sensitive small-cap bounce but questioned its durability given IWMs recent underperformance and continued concerns about elevated yields.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume rally without a disclosed company announcement is driving attention; traders credit possible institutional buying or short covering, while speculation about leaked news or an early FDA decision remains unconfirmed. The bullish discussion centers on Anktivas commercial growth and a pending U.S. label-expansion review, though some traders question the rallys durability without a clear catalyst.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A prolonged selloff has intensified amid concerns about slowing ad growth, competition from Amazon and Google, and managements response, with many traders criticizing executive option repricing. The community is also debating reports that Safari 27 blocks a Trade Desk ad-serving domain; some fear business impact, while others view it as a technical glitch whose effects remain unclear.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Reports that the Trump administration is preparing a roughly $4 billion loan to expand and modernize Vistras nuclear plants are driving attention, with traders viewing the financing as a boost to capacity amid rising AI and data-center power demand. The community reaction is broadly bullish, though some question the loans terms and point to VSTs volatile, choppy price action.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros stronger-than-expected YARTEMLEA launch and move to operating break-even are driving attention, with a Cantor Fitzgerald upgrade and higher sales expectations adding momentum; traders also cite Medicare reimbursement support as a potential boost to adoption. Bullish views on continued sales growth are tempered by concerns about the EMAs re-examination, insider stock sales, and whether the rally has outrun near-term fundamentals.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas steep post-earnings selloff and reduced outlook, which traders connect to weakness in Germany and continued investment spending, dominate the discussion. Many are frustrated by the persistent share-price weakness, while bullish traders argue the valuation is attractive and point to U.S. growth and the Apple financing partnership as longer-term opportunities.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital fell alongside Seagate after reports that Toshiba plans to expand HDD capacity for AI data centers, raising concerns about future competition and pressure on pricing. Many traders called the selloff an overreaction, arguing that the ramp is years away and AI-driven storage demand remains strong, while others saw the added supply as a risk to the industrys pricing power.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHDs resilience and strong run amid weakness in tech and growth stocks have fueled discussion of a rotation toward defensive, dividend-paying value investments. Many holders are adding or praising its income and stability, while others question its recent pullbacks and whether its yield justifies the risk compared with bonds or cash.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today

Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.48% on an annualized basis producing an average annual return of 17.52%. Currently, Incyte has a market capitalization of $23.82 billion.read more...

INCY or TECH: Which Is the Better Value Stock Right Now?

INCY vs. TECH: Which Stock Is the Better Value Option?

MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy

Mirum Pharmaceuticals wins FDA approval for Atebrioz in FOP, backed by PROGRESS data showing a reduction in new HO lesion volume.

LLY's Olumiant Gets FDA Nod for Expanded Use in Pediatric Hair Loss

Eli Lilly's Olumiant wins FDA nod to treat pediatric patients 12 years of age and older with severe alopecia areata, expanding its U.S. use after strong phase III results.

MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary

MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary MiniMed appoints Sheila Denton as General Counsel & Corporate SecretaryPR NewswireNORTHRIDGE, Calif., Sept. 28, 2026 NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes...

FDA Decision Watch: BMY, EGTX Face Key Decisions This Week As BFRI, SRRK And MIRM Score Early Approvals

Equity

Bristol Myers Squibb and Egetis await FDA decisions on treatments for heart and rare genetic conditions, while Scholar Rock, Biofrontera and Mirum have already secured regulatory wins ahead of schedule.


Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older...

INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill

The Food and Drug Administration’s target date is Saturday, September 26, for zilurgisertib, a once-daily pill for fibrodysplasia ossificans progressiva, or FOP, in patients 12 and older.


Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incytes Inflammation and Autoimmunity Portfolio

Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at...

FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week 

Merck, Mirum, Incyte and Grail are in focus this week as investors await key FDA decisions and a regulatory review involving treatments for lung disease, a rare bone disorder and cancer detection.


Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Incyte Corp.

Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

INCY Incyte Corp.

Fundamentals

Latest INCY News